Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

Conditions:   Asthma;   Rhinitis AllergicIntervention:   Drug: MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 WeeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials